EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Summative Comorbidities Are Independently Associated With Mortality in Patients With Hepatocellular Carcinoma

Tobias Meischl iD, Moritz Steurer, Lorenz Balcar iD, Yannick Marcour, Patrick Meier, Lukas Bucher, Ye-Rin Park, Katharina Pomej iD, Mattias Mandorfer iD, Thomas Reiberger iD, Michael Trauner, Bernhard Scheiner und 1 weitere

Liver International · 2026-07 · 46 (7)

DOI: 10.1111/liv.70721 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, online erschienen am 01.06.2026. Verfasst von Tobias Meischl und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Comorbidities might limit therapeutic options and negatively impact survival in patients with hepatocellular carcinoma (HCC). The Charlson Comorbidity Index (CCI) is widely used to summarize and quantify comorbidities.

Methods

HCC patients diagnosed between 1992 and 2018 at the Medical University of Vienna were retrospectively analysed. A modified CCI (mCCI), assigning no points for liver disease and HCC, was used to quantify comorbidities. The association of mCCI with clinical characteristics, overall survival (OS) and liver‐related survival (LrS) was analysed.

Results

Of 1359 evaluable patients, 628 (46.2%) had no relevant comorbidities (mCCI = 0 points), 626 (46.1%) had 1–2 points in the mCCI and 105 (7.7%) had ≥ 3 points. Mean age at diagnosis was 63.7 years (standard deviation ±10.1 years) and 1124 patients (82.7%) were male. In multivariable analysis, mCCI as a categorial (adjusted hazard ratio [aHR] for 1–2 points 1.20, 95% confidence interval [CI] 1.04–1.38; aHR for ≥ 3 points 1.58, 95% CI 1.22–2.04; p < 0.001) and continuous variable (aHR 1.13, 95% CI 1.06–1.20; p < 0.001) was independently associated with OS. Similarly, mCCI was a significant independent predictor of LrS, both as categorial (aHR for 1–2 points 1.19, 95% CI 0.95–1.50; aHR for ≥ 3 points 1.64, 95% CI 1.11–2.43; p = 0.031) and as continuous variable (aHR 1.11, 95% CI 1.02–1.22; p = 0.023).

Conclusions

The mCCI was significantly associated with OS and LrS, independent from established risk factors such as liver function and tumour extent. Whether comorbidities should be integrated into therapeutic algorithms in HCC warrants prospective evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansMaleMiddle AgedFemaleComorbidityRetrospective StudiesAgedAustriaRisk FactorsProportional Hazards Models

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Vienna Liver Cancer Study Group, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • 3rd Medical Department (Haematology & Oncology), Hanusch-Krankenhaus, Vienna, Austria.
  • Gesundheitszentrum Floridsdorf, Vienna, Austria.
  • 2nd Medical Department, Klinik Donaustadt, Vienna, Austria.
  • Hanusch-Krankenhaus, Vienna, Austria.

ORCID-Profile: Tobias Meischl, Lorenz Balcar, Katharina Pomej, Mattias Mandorfer, Thomas Reiberger, Matthias Pinter

Zitieren

APA

Meischl, T., Steurer, M., Balcar, L., Marcour, Y., Meier, P., Bucher, L., Park, Y. R., Pomej, K., Mandorfer, M., Reiberger, T., Trauner, M., Scheiner, B., & Pinter, M. (2026). Summative Comorbidities Are Independently Associated With Mortality in Patients With Hepatocellular Carcinoma. Liver International, 46(7). https://doi.org/10.1111/liv.70721

Vancouver

Meischl T, Steurer M, Balcar L, Marcour Y, Meier P, Bucher L, et al. Summative Comorbidities Are Independently Associated With Mortality in Patients With Hepatocellular Carcinoma. Liver International. 2026;46(7). doi:10.1111/liv.70721

BibTeX
@article{Meischl2026,
  author = {Meischl, Tobias and Steurer, Moritz and Balcar, Lorenz and Marcour, Yannick and Meier, Patrick and Bucher, Lukas and Park, Ye-Rin and Pomej, Katharina and Mandorfer, Mattias and Reiberger, Thomas and Trauner, Michael and Scheiner, Bernhard and Pinter, Matthias},
  title = {Summative Comorbidities Are Independently Associated With Mortality in Patients With Hepatocellular Carcinoma},
  journal = {Liver International},
  year = {2026},
  volume = {46},
  number = {7},
  doi = {10.1111/liv.70721}
}
Kostenlos starten →